A Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics

The fibrinogen (Fg) binding MSCRAMM Clumping factor A (ClfA) from Staphylococcus aureus interacts with the C-terminal region of the fibrinogen (Fg) γ-chain. ClfA is the major virulence factor responsible for the observed clumping of S. aureus in blood plasma and has been implicated as a virulence factor in a mouse model of septic arthritis and in rabbit and rat models of infective endocarditis. We report here a high-resolution crystal structure of the ClfA ligand binding segment in complex with a synthetic peptide mimicking the binding site in Fg. The residues in Fg required for binding to ClfA are identified from this structure and from complementing biochemical studies. Furthermore, the platelet integrin αIIbβ3 and ClfA bind to the same segment in the Fg γ-chain but the two cellular binding proteins recognize different residues in the common targeted Fg segment. Based on these differences, we have identified peptides that selectively antagonize the ClfA-Fg interaction. The ClfA-Fg binding mechanism is a variant of the “Dock, Lock and Latch” mechanism previously described for the Staphylococcus epidermidis SdrG–Fg interaction. The structural insights gained from analyzing the ClfANFg peptide complex and identifications of peptides that selectively recognize ClfA but not αIIbβ3 may allow the design of novel anti-staphylococcal agents. Our results also suggest that different MSCRAMMs with similar structural organization may have originated from a common ancestor but have evolved to accommodate specific ligand structures.

[1]  S. Ho,et al.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. , 2013, BioTechniques.

[2]  S. Narayana,et al.  Evidence for the “Dock, Lock, and Latch” Ligand Binding Mechanism of the Staphylococcal Microbial Surface Component Recognizing Adhesive Matrix Molecules (MSCRAMM) SdrG* , 2008, Journal of Biological Chemistry.

[3]  R. Weinstein,et al.  Community-associated Methicillin-resistant Staphylococcus aureus , 2006, Emerging infectious diseases.

[4]  L. Marraffini,et al.  Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria , 2006, Microbiology and Molecular Biology Reviews.

[5]  S. Narayana,et al.  A ‘Collagen Hug’ Model for Staphylococcus aureus CNA binding to collagen , 2005, The EMBO journal.

[6]  T. Foster.  Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.

[7]  P. Tsai,et al.  ClfA221–550, a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function , 2005, Thrombosis and Haemostasis.

[8]  E. Gorovits,et al.  Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus , 2005, Infection and Immunity.

[9]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .

[10]  J. Patti.  A humanized monoclonal antibody targeting Staphylococcus aureus. , 2004, Vaccine.

[11]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[12]  Barry S. Coller,et al.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics , 2004, Nature.

[13]  Katherine O'Riordan,et al.  Staphylococcus aureus Capsular Polysaccharides , 2004, Clinical Microbiology Reviews.

[14]  Julia M. Ross,et al.  Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA , 2003, Infection and Immunity.

[15]  Magnus Hook,et al.  A “dock, lock, and latch” Structural Model for a Staphylococcal Adhesin Binding to Fibrinogen , 2003, Cell.

[16]  M. Carson,et al.  A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen‐binding MSCRAMM, clumping factor A , 2002, The EMBO journal.

[17]  N. Day,et al.  Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus , 2002, Infection and Immunity.

[18]  D. Fitzgerald,et al.  Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A , 2002, Molecular microbiology.

[19]  Robert C. Liddington,et al.  Faculty Opinions recommendation of Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. , 2002 .

[20]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[21]  T. Foster,et al.  Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. , 2001, The Journal of infectious diseases.

[22]  V S Lamzin,et al.  ARP/wARP and molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[23]  P. François,et al.  Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis , 2001, Infection and Immunity.

[24]  S. Mazmanian,et al.  Sortase‐catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus , 2001, Molecular microbiology.

[25]  A. Cheung,et al.  Clumping Factor A Mediates Binding ofStaphylococcus aureus to Human Platelets , 2001, Infection and Immunity.

[26]  T. Foster,et al.  Identification of Residues in the Staphylococcus aureus Fibrinogen-binding MSCRAMM Clumping Factor A (ClfA) That Are Important for Ligand Binding* , 2001, The Journal of Biological Chemistry.

[27]  M. Höök,et al.  The Fibronectin-binding MSCRAMM FnbpA ofStaphylococcus aureus Is a Bifunctional Protein That Also Binds to Fibrinogen* , 2000, The Journal of Biological Chemistry.

[28]  J. Pflugrath,et al.  The finer things in X-ray diffraction data collection. , 1999, Acta crystallographica. Section D, Biological crystallography.

[29]  A. Conde.  Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[30]  T. Foster,et al.  Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.

[31]  P. François,et al.  Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus , 1998, Molecular microbiology.

[32]  R. Daum.  Community-acquired methicillin-resistant staphylococcus aureus infections. , 1998, The Pediatric infectious disease journal.

[33]  T. Foster,et al.  The Fibrinogen-binding MSCRAMM (Clumping Factor) ofStaphylococcus aureus Has a Ca2+-dependent Inhibitory Site* , 1998, The Journal of Biological Chemistry.

[34]  L. McIntire,et al.  Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. , 1997, European journal of biochemistry.

[35]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[36]  W. Foss,et al.  Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis , 1996, Infection and immunity.

[37]  P. François,et al.  Identification of the ligand‐binding domain of the surface‐located fibrinogen receptor (clumping factor) of Staphylococcus aureus , 1995, Molecular microbiology.

[38]  P. François,et al.  Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus , 1994, Molecular microbiology.

[39]  D S Moss,et al.  Main-chain bond lengths and bond angles in protein structures. , 1993, Journal of molecular biology.

[40]  S. Lord,et al.  The Residues AGDV of Recombinant γ Chains of Human Fibrinogen Must Be Carboxy-Terminal to Support Human Platelet Aggregation , 1992, Thrombosis and Haemostasis.

[41]  E. Davie,et al.  Role of fibrinogen alpha and gamma chain sites in platelet aggregation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[43]  M. Bednarek,et al.  Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. , 1989, Biochemistry.

[44]  K. Kristinsson.  Adherence of staphylococci to intravascular catheters. , 1989, Journal of medical microbiology.

[45]  Mike Carson,et al.  Ribbon models of macromolecules , 1987 .

[46]  P. Tsai,et al.  A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in mice. , 2007, Thrombosis research.

[47]  Paul M. Orwin,et al.  Exotoxins of Staphylococcus aureus. , 2000, Clinical microbiology reviews.

[48]  J. Sambrook,et al.  Protein structure. Chaperones, paperones. , 1989, Nature.